Nureca

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE0DSF01015
  • NSEID: NURECA
  • BSEID: 543264
INR
282.00
-9 (-3.09%)
BSENSE

Feb 11

BSE+NSE Vol: 21.26 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003462,
    "name": "Nureca",
    "stock_name": "Nureca",
    "full_name": "Nureca Ltd",
    "name_url": "stocks-analysis/nureca",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "282.00",
    "chg": -9,
    "chgp": "-3.09%",
    "dir": -1,
    "prev_price": "291.00",
    "mcapval": "274.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543264,
    "symbol": "NURECA",
    "ind_name": "Healthcare Services",
    "ind_code": 26,
    "indexname": "",
    "isin": "INE0DSF01015",
    "curr_date": "Feb 11",
    "curr_time": "",
    "bse_nse_vol": "21.26 k",
    "exc_status": "Active",
    "traded_date": "Feb 11, 2026",
    "traded_date_str": "2026 02 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/nureca-1003462-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Nureca Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nureca-ltd-is-rated-hold-by-marketsmojo-3830389",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NurecaLtd_mojoScore_3830389.png",
        "date": "2026-02-10 10:11:11",
        "description": "Nureca Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 17 January 2026. While this rating change reflects the company’s evolving outlook, the analysis below is based on the stock’s current fundamentals, returns, and financial metrics as of 10 February 2026, providing investors with an up-to-date perspective on its investment potential."
      },
      {
        "title": "Nureca Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nureca-ltd-is-rated-hold-by-marketsmojo-3810995",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NurecaLtd_mojoScore_3810995.png",
        "date": "2026-01-30 10:11:27",
        "description": "Nureca Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 17 January 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 30 January 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Nureca Ltd Falls 9.26%: 3 Key Factors Driving the Weekly Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nureca-ltd-falls-926-3-key-factors-driving-the-weekly-decline-3803208",
        "imagepath": "",
        "date": "2026-01-24 11:05:02",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Jan 19:</strong> Stock surged to upper circuit at ₹322.05 (+5.0%)</p>\n                    <p><strong>Jan 20:</strong> Sharp reversal hitting lower circuit at ₹310.55 (-4.94%)</p>\n                    <p><strong>Jan 22:</strong> Continued decline to ₹290.10 (-3.20%)</p>\n                    <p><strong>Jan 23:</strong> Week closes at ₹282.15 (-2.74%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.310.95</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.282.15</div><div class=\"stat-chang..."
      },
      {
        "title": "Nureca Ltd Hits Lower Circuit Amid Heavy Selling Pressure and Panic Selling",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nureca-ltd-hits-lower-circuit-amid-heavy-selling-pressure-and-panic-selling-3795745",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NurecaLtd_stocks_hitting_lower_circuit_3795745.png",
        "date": "2026-01-20 10:00:22",
        "description": "Shares of Nureca Ltd, a micro-cap player in the Healthcare Services sector, plunged sharply on 20 Jan 2026, hitting the lower circuit limit amid intense selling pressure. The stock recorded its maximum daily loss in recent months, reflecting a sudden shift in investor sentiment and panic selling that overwhelmed available supply."
      },
      {
        "title": "Nureca Ltd Surges to Upper Circuit Amid Robust Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nureca-ltd-surges-to-upper-circuit-amid-robust-buying-pressure-3794315",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NurecaLtd_stocks_hitting_upper_circuit_3794315.png",
        "date": "2026-01-19 10:00:25",
        "description": "Nureca Ltd, a micro-cap player in the healthcare services sector, surged to hit its upper circuit limit on 19 Jan 2026, propelled by robust buying interest and sustained investor enthusiasm. The stock closed at ₹322.05, marking a maximum daily gain of 3.27%, outperforming its sector and broader market indices amid heightened liquidity and demand."
      },
      {
        "title": "Nureca Ltd Upgraded to Hold by MarketsMOJO on Improving Technicals and Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nureca-ltd-upgraded-to-hold-by-marketsmojo-on-improving-technicals-and-financials-3793847",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NurecaLtd_mojoScore_3793847.png",
        "date": "2026-01-19 08:11:09",
        "description": "Nureca Ltd, a player in the healthcare services sector, has seen its investment rating upgraded from Sell to Hold as of 17 January 2026. This change reflects a combination of improved technical indicators, steady financial results, and a more balanced valuation outlook despite lingering concerns over long-term fundamentals and profitability. The stock’s recent price action and quarterly performance have prompted analysts to reassess its prospects amid a challenging industry backdrop."
      },
      {
        "title": "Why is Nureca Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-nureca-ltd-fallingrising-3793219",
        "imagepath": "",
        "date": "2026-01-17 01:00:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Momentum and Market Outperformance</strong></p>\n<p>The stock has demonstrated significant upward momentum over the past week, delivering a 9.95% gain compared to a flat Sensex performance. Over the last month, Nureca outpaced the benchmark by a wide margin, rising 13.57% while the Sensex declined by 1.31%. Year-to-date, the stock has managed a modest 1.07% increase, again outperforming the Sensex’s 1.94% decline. This recent rally is further underscored by a three-day consecutive gain period, during which the stock appreciated by 11.79%, signalling sustained buying interest.</p>\n<p>Intraday trading on 16-Jan saw the stock touch a high of Rs 310.95, marking a 5% increase from the previous close, despite an intraday low of Rs 288.6. Notably, Nureca is trading above all key moving ..."
      },
      {
        "title": "Nureca Ltd Upgraded to Hold as Technicals and Financials Show Mixed Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nureca-ltd-upgraded-to-hold-as-technicals-and-financials-show-mixed-signals-3782771",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NurecaLtd_mojoScore_3782771.png",
        "date": "2026-01-06 08:52:26",
        "description": "Nureca Ltd, a player in the Healthcare Services sector, has seen its investment rating upgraded from Sell to Hold as of 5 January 2026. This change reflects a combination of improved technical indicators, robust recent financial results, and rising promoter confidence, despite lingering concerns over long-term fundamentals and valuation risks."
      },
      {
        "title": "Nureca Ltd Gains 6.05%: 2 Key Events Shaping the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nureca-ltd-gains-605-2-key-events-shaping-the-week-3779512",
        "imagepath": "",
        "date": "2026-01-03 11:39:00",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>29 Dec 2025:</strong> Downgrade to Sell by MarketsMOJO</p>\n                    <p><strong>31 Dec 2025:</strong> Stock hits upper circuit limit at Rs.307.95</p>\n                    <p><strong>2 Jan 2026:</strong> Week closes at Rs.302.50 (+6.05%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.285.25</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.302.50</div><div class=\"stat-change positive\">+6.05%</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week ..."
      }
    ],
    "total": 247,
    "sid": "1003462",
    "stock_news_url": "https://www.marketsmojo.com/news/nureca-1003462"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011",
      "datetime": "31-Jan-2026",
      "details": "The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(i)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Saurabh Goyal Aryan Goyal Payal Goyal Smita Goyal & Nectar Biopharma Pvt Ltd",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "28-Jan-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Saurabh Goyal & Others",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011",
      "datetime": "28-Jan-2026",
      "details": "The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Saurabh Goyal & Others",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Nureca Ltd has declared <strong>30%</strong> dividend, ex-date: 24 Feb 22",
          "dt": "2022-02-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Nureca Ltd Falls 9.26%: 3 Key Factors Driving the Weekly Decline

2026-01-24 11:05:02

Key Events This Week

Jan 19: Stock surged to upper circuit at ₹322.05 (+5.0%)

Jan 20: Sharp reversal hitting lower circuit at ₹310.55 (-4.94%)

Jan 22: Continued decline to ₹290.10 (-3.20%)

Jan 23: Week closes at ₹282.15 (-2.74%)

Why is Nureca Ltd falling/rising?

2026-01-17 01:00:03

Recent Price Momentum and Market Outperformance

The stock has demonstrated significant upward momentum over the past week, delivering a 9.95% gain compared to a flat Sensex performance. Over the last month, Nureca outpaced the benchmark by a wide margin, rising 13.57% while the Sensex declined by 1.31%. Year-to-date, the stock has managed a modest 1.07% increase, again outperforming the Sensex’s 1.94% decline. This recent rally is further underscored by a three-day consecutive gain period, during which the stock appreciated by 11.79%, signalling sustained buying interest.

Intraday trading on 16-Jan saw the stock touch a high of Rs 310.95, marking a 5% increase from the previous close, despite an intraday low of Rs 288.6. Notably, Nureca is trading above all key moving ...

Read full news article
stock-recommendationAnnouncement

Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011

31-Jan-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(i)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Saurabh Goyal Aryan Goyal Payal Goyal Smita Goyal & Nectar Biopharma Pvt Ltd

Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011

28-Jan-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Saurabh Goyal & Others

Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011

28-Jan-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Saurabh Goyal & Others

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Nureca Ltd has declared 30% dividend, ex-date: 24 Feb 22

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available